Liver transplantation in NET disease: Expert consensus and clinical updates
In this webinar, participants will receive an overview of the latest updates and key challenges in liver transplantation for patients with neuroendocrine tumours (NETs), based on the relevant ENETS guidance paper. A panel of international experts will present a clinical case, review current data on liver transplantation, and summarise existing guidelines while discussing recent developments in the field.
In particular, the session will explore whether liver transplantation in NET patients should be considered as a curative option or primarily a palliative approach, offering valuable clinical insights and perspectives.
This free webinar is open to all healthcare professionals and specifically is designed for participants with an intermediate level of knowledge and experience.
For further reading, see the newly published ENETS position statement:
Stålberg P, et al. Controversies in NEN: An ENETS position statement on the role of liver transplantation (LT) in patients with advanced small-intestinal and pancreatic NETs. Journal of Neuroendocrinology. 2026;38(10). doi:10.1111/jne.70250.
Educational Level:
Downloads:
Agenda:
Moderator: Peter Stålberg (SWE)
18:00 – 18:05 Opening comments – Peter Stålberg (SWE)
18:05 – 18:15 Case presentation – Raj Srirajaskanthan (GBR)
18:15 – 18:30 Data on liver transplant and current guidelines – Andreas Pascher (GER)
18:30 – 18:45 Liver transplant for NET- liver metastases - promise for cure or rather palliation? – Julie Hallet (CAN)
18:45 – 19:05 Discussion
-
-
- Peter Stålberg (SWE)
- Raj Srirajaskanthan (GBR)
- Andreas Pascher (GER)
- Julie Hallet (CAN)
- Adina Croitoru (ROM)
-
19:05 – 19:10 Closing comments – Peter Stålberg (SWE)
Moderators:
Speakers:
The webinar series is intended for HCPs qualified by law to prescribe medicine.
Conflict of Interest Disclosure
In line with EACCME® standards, all faculty participating in this webinar have disclosed any potential conflicts of interest. The disclosures are available to all participants before and during the webinar session.
- Peter STÅLBERG (moderator) has no potential conflict of interest to report.
- Adina CROITORU (speaker) reports the following potential conflicts of interest:
- Receipt of grants/research supports: Amgen, Astellas, BMS, Can-Fite, ICON, Merck, MSD and Roche.
- Receipt of honoraria or consultation fees: Amgen, Astellas Pharma, AstraZeneca, Bayer, BMS, Genekor, Genesis Biopharma, Ipsen, Lilly, Merck, Novartis, Roche, Servier and Takeda.
- Travel and accommodation support: Accord, AstraZeneca, Genesis Biopharma and Roche.
- Julie HALLET (speaker) reports the following potential conflicts of interest:
- Receipt of honoraria or consultation fees: Ipsen, Novartis.
- Andreas PASCHER (speaker) reports the following potential conflicts of interest:
- Receipt of honoraria or consultation fees: IPSEN, Novartis.
- Raj SRIRAJASKANTHAN (speaker) reports the following potential conflicts of interest:
- Receipt of grants/research supports: Novartis, Ipsen.
- Receipt of honoraria or consultation fees: Novartis, Ipsen, Terumo, ITM, Advanz.
UEMS-EACCME® Accreditation Statement
The ENETS Webinar: Liver transplantation in NET disease - Expert consensus and clinical updates, Virtual, Germany, 30/09/2026 - 30/09/2026, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.